Skip to main content
Clinical Trials/KCT0005212
KCT0005212
Recruiting
未知

Validation for clinical utility of biomarkers for the early diagnosis of breast cancer

Seoul National University Hospital0 sites496 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Seoul National University Hospital
Enrollment
496
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Observational Study
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Breast Cancer patients
  • \- Women over 18
  • \- Patients diagnosed with breast cancer by biopsy before treatment (patients before surgery and neoadjuvant chemotherapy)

Exclusion Criteria

  • \- Carcinoma in situ
  • \- Recurrent breast cancer patient
  • \- Any person diagnosed with another cancer within five years.
  • \- Patients who started treatment after being diagnosed with breast cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Phyisician Led CIMAvax-EGF lung biomarkersAdvanced non small cell lung cancerCarcinoma, Non-Small-Cell LungCarcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract Diseases
RPCEC00000355Center of Molecular Immunology (CIM)140
Completed
Phase 4
Relevance of Biomarkers and Clinical Predictors of Outcome in Unselected Population with Febrile Urinary Tract Infection at Primary Care and Emergency Department in a Prospective, Randomized Cohort Trial Comparing Short (7 days) Antibiotic Treatment with Conventional Treatment (14 days)febrile urinary tract infection or pyelonephritis1000401810046590
NL-OMON39150eids Universitair Medisch Centrum500
Active, not recruiting
Not Applicable
Relevance of Biomarkers and Clinical Predictors of Outcome in Unselected Population with Febrile Urinary Tract Infection at Primary Care and Emergency Department in a Prospective, Randomized Cohort Trial Comparing Short (7 days) Antibiotic Treatment with Conventional Treatment (14 days) - FUTIRST (Febrile Urinary Tract Infection Randomized Short Treatment)
EUCTR2008-001081-80-NLeiden University Medical Center500
Recruiting
Not Applicable
Febrile Urinary Tract Infection Randomized Short Treatment Trial.urinary tarct infection, acute pyelonephritis, urosepsis
NL-OMON20802eiden University Medical Center400
Recruiting
Not Applicable
Pilot study: clinical evaluation of biomarkers as predictors of survival in castrate-resistant prostate cancer patients.
NL-OMON34838niversitair Medisch Centrum Sint Radboud50